Keystone E C, Jaglal S, Shore A
J Rheumatol. 1986 Oct;13(5):944-7.
We examined the spontaneous secretion of interleukin 1 (IL-1) from peripheral blood monocytes and staphylococcal protein A (SPA) induced secretion of interleukin 2 (IL-2) from peripheral blood mononuclear cells from 13 patients with active ankylosing spondylitis and 10 healthy controls. IL-1 and IL-2 secretion in the patient group was not measurably different from controls (p greater than 0.05). We also examined IL-1 and IL-2 generation in 7 patients before and 2 months after therapy with a nonsteroidal antiinflammatory agent, piroxicam. A variable effect of piroxicam was observed on IL-1 and IL-2 generation despite the efficacy of piroxicam in reducing the clinical activity of the disease. Our results suggest the absence of an intrinsic aberration in IL generation from peripheral blood cells from patients with ankylosing spondylitis.
我们检测了13例活动期强直性脊柱炎患者外周血单核细胞白细胞介素1(IL-1)的自发分泌以及葡萄球菌蛋白A(SPA)诱导的外周血单个核细胞白细胞介素2(IL-2)的分泌,并与10名健康对照者进行了比较。患者组中IL-1和IL-2的分泌与对照组相比无显著差异(p>0.05)。我们还检测了7例患者在使用非甾体抗炎药吡罗昔康治疗前及治疗2个月后的IL-1和IL-2生成情况。尽管吡罗昔康在降低疾病临床活动度方面有效,但观察到其对IL-1和IL-2生成的影响不一。我们的结果提示强直性脊柱炎患者外周血细胞IL生成不存在内在异常。